
STAAR Surgical Company STAA
$ 29.87
-0.3%
Quarterly report 2026-Q1
added 05-13-2026
STAAR Surgical Company DIO Ratio 2011-2026 | STAA
Annual DIO Ratio STAAR Surgical Company
| 2026 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 164 | - | 188 | 190 | 238 | 219 | 208 | - | 219 | 195 | 96.8 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 238 | 96.8 | 191 |
Quarterly DIO Ratio STAAR Surgical Company
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 126 | - | - | - | 114 | - | 221 | 213 | 213 | - | 221 | 205 | 99.9 | - | 208 | 182 | 194 | - | 227 | 218 | 224 | - | 207 | 184 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 227 | 99.9 | 191 |
DIO Ratio of other stocks in the Medical instruments industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
213 | $ 68.62 | 2.74 % | $ 13.7 B | ||
|
Glaukos Corporation
GKOS
|
198 | $ 126.34 | 3.59 % | $ 7.23 B | ||
|
Luminex Corporation
LMNX
|
265 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
66.1 | - | -9.52 % | $ 20.6 M | ||
|
Intuitive Surgical
ISRG
|
177 | $ 426.61 | 1.91 % | $ 152 B | ||
|
Alcon
ALC
|
126 | $ 67.9 | 2.71 % | $ 40.4 B | ||
|
ICU Medical
ICUI
|
155 | $ 142.0 | 3.29 % | $ 3.5 B | ||
|
iRhythm Technologies
IRTC
|
29.6 | $ 113.83 | 6.15 % | $ 3.64 B | ||
|
Repro Med Systems
KRMD
|
76.2 | $ 4.0 | 0.25 % | $ 185 M | ||
|
LeMaitre Vascular
LMAT
|
338 | $ 96.59 | 1.56 % | $ 2.19 B | ||
|
Masimo Corporation
MASI
|
168 | $ 179.95 | 0.01 % | $ 9.59 B | ||
|
Antares Pharma, Inc.
ATRS
|
105 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
106 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
0.917 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
91.4 | - | -0.05 % | $ 10.3 B | ||
|
Ekso Bionics Holdings
EKSO
|
288 | - | - | $ 28.6 M | ||
|
Milestone Scientific
MLSS
|
533 | $ 0.39 | 0.29 % | $ 32 M | ||
|
Varian Medical Systems, Inc.
VAR
|
105 | - | -0.02 % | $ 16.3 B | ||
|
Merit Medical Systems
MMSI
|
150 | $ 67.51 | 2.24 % | $ 3.99 B | ||
|
electroCore
ECOR
|
142 | $ 9.52 | -1.24 % | $ 80.8 K | ||
|
Envista Holdings Corporation
NVST
|
78.3 | $ 24.59 | 4.91 % | $ 4.13 B | ||
|
Haemonetics Corporation
HAE
|
224 | $ 78.71 | 5.11 % | $ 3.71 B | ||
|
STERIS plc
STE
|
66.9 | $ 212.88 | 1.1 % | $ 20.9 B | ||
|
Isoray
ISR
|
159 | - | 0.03 % | $ 108 M | ||
|
InfuSystem Holdings
INFU
|
34.5 | $ 9.01 | - | $ 186 M | ||
|
Teleflex Incorporated
TFX
|
149 | $ 135.75 | 3.04 % | $ 6.06 B | ||
|
Utah Medical Products
UTMD
|
185 | $ 68.07 | 1.52 % | $ 221 M | ||
|
West Pharmaceutical Services
WST
|
76 | $ 334.66 | 4.66 % | $ 24.2 B | ||
|
Pulse Biosciences
PLSE
|
46 | $ 25.77 | 3.74 % | $ 1.74 B | ||
|
DENTSPLY SIRONA
XRAY
|
120 | $ 10.47 | 2.05 % | $ 2.09 B | ||
|
Retractable Technologies
RVP
|
174 | $ 0.69 | 0.16 % | $ 20.7 M | ||
|
Pro-Dex
PDEX
|
145 | $ 65.0 | - | $ 214 M | ||
|
Predictive Oncology
POAI
|
115 | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
317 | $ 27.55 | 5.56 % | $ 1.32 B | ||
|
Stereotaxis
STXS
|
213 | $ 1.85 | 2.21 % | $ 168 M | ||
|
Baxter International
BAX
|
99.3 | $ 20.03 | 4.16 % | $ 10.3 B | ||
|
ResMed
RMD
|
141 | $ 196.94 | 1.97 % | $ 28.8 B | ||
|
AtriCure
ATRC
|
210 | $ 27.3 | 1.43 % | $ 1.3 B | ||
|
Harvard Bioscience
HBIO
|
219 | $ 6.04 | 0.5 % | $ 268 M | ||
|
NeuroMetrix
NURO
|
392 | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
166 | $ 12.34 | 3.44 % | $ 504 M | ||
|
Becton, Dickinson and Company
BDX
|
119 | $ 152.04 | 2.08 % | $ 43.7 B | ||
|
Nephros
NEPH
|
149 | $ 3.25 | -4.13 % | $ 34.5 M | ||
|
OraSure Technologies
OSUR
|
178 | $ 4.24 | 2.17 % | $ 312 M | ||
|
Repligen Corporation
RGEN
|
162 | $ 130.13 | 3.83 % | $ 7.32 M |